newsfilter
← Latest News
GlobeNewswire·

Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program

FORT LAUDERDALE, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE:SBEV) ("Splash" or the "Company") today announced that it has expanded its exclusive global license for